Patents by Inventor Daniela Hoefler

Daniela Hoefler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10731228
    Abstract: The present invention relates to a method for differentiating in a subject with HR-HPV between a severe form of HR-HPV infection and a mild form of HR-HPV infection. It further is concerned with a composition comprising a probe oligonucleotide mixture, a device, and a kit for use in conjunction with the method of the invention.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: August 4, 2020
    Assignee: Deutsches Krebsforschungszentrum
    Inventors: Markus Schmitt, Lutz Gissmann, Michael Pawlita, Daniela Hoefler
  • Publication number: 20180094326
    Abstract: The present invention relates to a method for differentiating in a subject with HR-HPV between a severe form of HR-HPV infection and a mild form of HR-HPV infection. It further is concerned with a composition comprising a probe oligonucleotide mixture, a device, and a kit for use in conjunction with the method of the invention.
    Type: Application
    Filed: October 19, 2017
    Publication date: April 5, 2018
    Applicant: Deutsches Krebsforschungszentrum
    Inventors: Markus SCHMITT, Lutz GISSMANN, Michael PAWLITA, Daniela HOEFLER
  • Patent number: 9816149
    Abstract: The present invention relates to a method for differentiating in a subject with HR-HPV between a severe form of HR-HPV infection and a mild form of HR-HPV infection. It further is concerned with a composition comprising a probe oligonucleotide mixture, a device, and a kit for use in conjunction with the method of the invention.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: November 14, 2017
    Assignee: Deutsches Krebsforschungzentrum
    Inventors: Markus Schmitt, Lutz Gissmann, Michael Pawlita, Daniela Hoefler
  • Publication number: 20110275059
    Abstract: The present invention relates to a method for differentiating in a subject with HR-HPV between a severe form of HR-HPV infection and a mild form of HR-HPV infection. It further is concerned with a composition comprising a probe oligonucleotide mixture, a device, and a kit for use in conjunction with the method of the invention.
    Type: Application
    Filed: May 4, 2011
    Publication date: November 10, 2011
    Applicant: DEUTSCHES KREBSFORSCHUNGSZENTRUM
    Inventors: Markus Schmitt, Lutz Gissmann, Michael Pawlita, Daniela Hoefler